Goodwin-Led Pliant Therapeutics Shares Pop After $144M IPO
Pliant Therapeutics' shares got off to a soaring start Wednesday after the biopharmaceutical company raised $144 million in an initial public offering steered by Goodwin Procter and Morrison & Foerster that priced...To view the full article, register now.
Already a subscriber? Click here to view full article